{"text":"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Percent remaining of radioligand [3H]DPCPX binding to human adenosine A1 receptor at 10 uM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Saturation binding of human Adenosine A2A receptor (H250N) at pH 6.8","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]-SCH- 58261 from human adenosine A2A receptor expressed in CHO cells; range 65-92","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity towards human alpha-2 adrenergic receptor","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of DHT from human androgen receptor","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Median survival time (% T\/C) after ip administration of a dose of 4 mg\/kg\/day in B-16 melanoma in mice","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was evaluated for the in vitro inhibition of the Butyrylcholinesterase from horse serum","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ability to interact with DNA was assessed by a DNA\/ethidium bromide dye displacement assay, expressed as DC50 for polydAdT","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"In vitro for its ability to displace [3H]- spiperone from cloned human Dopamine receptor D4 expressed in CHO cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Effect on the activity of elastase was determined","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Irreversible antagonism to morphine was evaluated after 30 min incubation of GPI with the compound at 1000 nM conc.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In vitro inhibitory activity against HMG CoA reductase","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiviral activity against herpes simplex virus type I was measured at 5 uM concentration.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Dose required to achieve 50% protection of MT-4 cells from HIV-1(IIIB) induced cytopathogenicity, determined by MIT method.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of Rauscher leukemia virus in female BALB\/c mice. Compound is administered perorally at 125 mg\/kg for 5 days a week for 4 weeks (exp 1); treated\/control= 46.8\/46.0","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Uterotrophic activity in immature mouse","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for the ability to displace mu-receptor specific radioligand [3H]DAGO","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for its binding affinity to Poly (dA-dT) by using ethidium displacement assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity for poly dA-dT DNA by measuring the change in midpoint of the thermal denaturation curves","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ability to displace ethidium bromide from double stranded synthetic poly (dG-dC)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Tested for binding association constant against Poly (dG-dC) using ethidium bromide assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Opioid agonist activity by measuring the analgesia produced after 10 mg\/kg administration in rats; none","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Percent decrease in angiotensin I pressor response was measured in rat, administered intravenously at dose 0.010 mg\/kg","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition rat liver microsomal squalene synthase","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for relative binding affinity against calf uterine receptor using [3H]estradiol as radioligand","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"inhibition of the growth of renal cancer(UO-31) cell line","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Vibrio cholerae 0139","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Compound was evaluated for the binding constant for association with nicotinic acetylcholine receptor (nAChR)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against HEK293 cells relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of Mycobacterium tuberculosis InhA","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of 3H]RX821002 from rat cortex adrenergic alpha-2 receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]SR141716A from human CB1 receptor expressed in CHO cells at 10 uM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]MK-801 from rat brain NMDA receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Escherichia coli MC4100 assessed as inhibition zone at >2 mg\/mL","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of TNF-alpha-induced E-selectin expression in HUVEC cells at 90 ug\/ml after 2 hrs by flow cytometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human ERbeta","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells at 1000 nM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Activity of rat liver 3-alpha-HSD assessed as formation of corresponding (S)-alcohol products per mg of protein","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Staphylococcus aureus ATCC 25923 at 400 ug\/disc after 18 hrs by disc diffusion assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to calf thymus DNA","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA assessed as intercalation after 24 hrs by DNA-methyl green assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Anxiolytic-like activity in ddY mouse assessed as ambulatory activity at 1 mg\/kg, po for 7 days measured 24 hrs after final drug administration assessed per 5 mins by tilting type ambulometer test","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human MDA-MB-435 cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human A2780 cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human HOP62 cells assessed as age growth inhibition at 100 uM after 48 hrs by sulforhodamine B assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Stabilization of human G4-telomeric quadruplex assessed as melting temperature by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 3 uM under Na+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as quadruplex stabilization at 3 uM by FRET assay in presence of duplex ds26 oligonucleotide","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 0.3 uM under K+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 0.8 uM under K+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric G-quadruplex F21T DNA assessed as change in melting temperature at 2.0 uM by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex HTG21 oligomer by fluorescence titration experiment","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of 2-[125I]iodomelatonin from human MT1 receptor expressed in HEK293 cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 18 ug\/ml after 6 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of ALK7 expressed in baculovirus\/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at human 5HT1A receptor expressed in CHO cells by [35S]GTPgammaS binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human NCI-H23 cells assessed as cell growth at 0.1 uM after 1 to 11 days by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cell cycle arrest in human A2780 cells assessed as accumulation at subG1 phase at 0.5 uM after 24 hrs by propidium iodide staining-based FACS analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae with Ile449Val, Asn526Lys substitutions in penicillin-binding protein 3 by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to (CAG-CAG) trinucleotide repeats at 120 uM by ESI-TOF mass spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Escherichia coli ATCC 25922 AmpC","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Legionella pneumophila ATCC 33153 infected in THP1 cells after 48hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of p110alpha\/p85alpha at 10 uM after 60 mins by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of EC50 for HIV1 TM harboring L10I\/K14R\/R41K\/M46L\/I54V\/L63P\/A71V\/V82A\/L90M\/I93L in protease encoding region to EC50 for HIV1 ERS104pre","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of [125I]-Tyr11-somatostatin 14 from SST5 receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against 5-fluorocytosine resistant Candida glabrata isolate TE34-78 harboring Fcr1 L136R mutant assessed as lowest concentration inhibiting growth >=80% by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antibacterial activity against Salmonella by broth macrodilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Induction of apoptosis in human Raji cells assessed as late apoptotic or secondary necrotic cells at 10 uM after 24 hrs by measuring phosphatidylserine translocation using annexin V-FITC\/propidium iodide staining by FACS (Rvb = 2.2 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to SAM1 riboswitch aptamer assessed as change in heat at 0.5 mM at pH 7.5 by Isothermal titration calorimetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in melting temperature at drug\/DNA ratio 0.2","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding constant for NIM1 kinase domain","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-GCGATATATGCG-3' DNA sequence in PBS buffer of pH 7.4 assessed as change in melting temperature by by UV-VIS spectrophotometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to telomeric G-quadruplex DNA 5'-d(GOxodGTTAGGGTTAGGGTTAGGGTTAGGG) at 1 to 10 uM by CD titration method in presence of 100 mM of KCl","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex in first binding event at 480 to 640 uM every 300 to 400 secs at pH 7 by isothermal titration calorimetry analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex in second binding event at 480 to 640 uM every 300 to 400 secs at pH 7 by isothermal titration calorimetry method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to duplex DNA d(CGCGAATTCGCG)2 duplex at pH 7 by isothermal titration calorimetry method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex assessed as melting temperature at 1:2 compound to DNA ratio at pH 7 by UV-visible spectrophotometer analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to ctu1-deficient Schizosaccharomyces pombe Lys-tRNA using 32P-labelled probe by PAGE analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in absorption spectra at increasing concentration at pH 8 by UV-Vis spectra analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of A73U tRNA(Tyr)-5'Rhd-AM1A T box antiterminator RNA complex assessed as reduction in anisotrophy changes by at 100 uM by fluorescence anisotropy-based assay relative to untreated control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as bathochromic shift at 1 x 10'-5 M by UV-Vis spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-ACCGGT-3' sequence in 125 bp 5'-[32P]-radiolabeled DNA at 100 uM after 30 mins by DNase1 footprinting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to poly-d(AT)2 DNA by UV titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA in presence of citrate-phosphate buffer at pH 7 by spectrophotometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as partial clear inhibition zone at 50 uL of 2 mM solution of compound in 1:9 DMSO\/MeOH after 24 hrs by agar diffusion method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq\/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay relative to 1-(4-(6-benzylbenzofuran-2-yl)-3-fluorobenzyl)azetidine-3-carboxylic acid","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimigraine activity in marmosets assessed as inhibition of CGRP-induced increase in facial blood flow at 1 mg\/kg, sc administered 30 mins post CGRP-challenge measured up to 105 mins by laser doppler flowmetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antitumor activity against human A549 cells xenografted in nu\/nu mouse assessed as inhibition of tumor volume at 3 mg\/kg, ip administered three times a week for 3 weeks","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human MDA-MB-231 cells after 72 hrs by celltiter-blue viability assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiobesity activity in po dosed wild type DIO C57 mouse assessed as reduction of food intake","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of CAMK2beta (unknown origin) assessed as remaining activity at 10 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human A549\/ATCC cells after 48 hrs by SRB assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5HT2A receptor (unknown origin)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cell cycle arrest in human MGC803 cells assessed as reduction in G1 phase accumulation after 12 to 24 hrs by propidium iodide staining-based flow cytometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human purified His-tagged DPP-7 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as conformational changes in DNA morphology at 50 mM after 2 hrs by circular dichroism analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to N-terminal domain of human Hsp90alpha by FAXS competitive binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiinflammatory activity in human THP1 cells assessed as inhibition of TPA\/ionomycin-induced extracellular IL-1beta level at 3 uM incubated 1 hr prior to TPA\/ionomycin challenge measured after 24 hrs by ELISA","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of Saccharomyces cerevisiae BY4742 harboring gcn5delta mutant after 48 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antagonist activity at Pseudomonas aeruginosa PAO1 LasR expressing lasI coexpressing LVA-GFP at 100 to 200 uM after 24 hrs by fluorescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to M4 receptor (unknown origin) by PDSP assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human NCI-H226 cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antihypertensive activity in Wistar rat assessed as mean arterial pressure at 10 mg\/kg, ip measured immediately at 0 min (Rvb = 194.08 +\/- 1.962 mmHg)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human A549 cells assessed as necrotic cells at 5 uM after 48 hrs by annexin V\/PI staining-based FACS analysis (Rvb = 2.8 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of microbial growth incubated for 24 hrs by broth dilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Intrinsic activity at GAL4 tagged human PPARalpha ligand binding domain expressed in HEK293 cells at 1 uM by luciferase reporter gene assay relative to 1 uM GW2331","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of MAO-B (unknown origin) by MAo-Glo kit analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs by twofold dilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of human ERG","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [125I]Endothelin-1 from human recombinant Endothelin-B receptor expressed in CHO cells at 10'-5 M","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of biotinylated ligand from recombinant His-tagged EP300 (unknown origin) incubated for 10 mins by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Effect on ITGB2 gene expression in serum-starved HUVEC after 6 hrs by microarray analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potency index, ratio of cyclosporine A IC50 to compound IC50 for ABCB1 in human A2780\/ADR cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Analgesic activity in CFA-induced mechanical hyperalgesia C57BL\/6J mouse model assessed as mechanical paw withdrawal threshold at 3 ug\/10 uL administered intrathecally 2 days after CFA injection measured at 90 to 150 mins post dose","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimalarial activity against Plasmodium yoelii YM infected in BALB\/c mouse assessed as parasite cure level at 10 to 90 mg\/kg, ip administered on days 1 post infection by Giemsa-stained microscopic analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of LTB4 biosynthesis in LPS-induced C57BL\/6 mouse model of acute lung injury BLAF at 25 mg\/kg, ip by ELISA","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Competitive inhibition of human mTOR using 4EBP1 as substrate in presence of [33gammaP]-ATP after 120 mins by filter binding method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Increase in OPG mRNA expression in mouse MC3T3-E1 cells up to 4 uM after 48 hrs in presence of ascorbic acid and beta-glycerophosphate by real-time PCR analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as time at which amplitude of ThT emission is 50% of difference between final and initial fluorescence emission at 40 to 5000 uM in presence of trehalose by ThT-based fluorometric method (Rvb = 11 +\/- 1 hrs)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to MAPK1 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of PKC-theta (unknown origin) at 0.45 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of SLK (unknown origin) at 0.19 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of FMS (unknown origin) assessed as remaining activity at 7.81 x 10'-8 M after 120 mins in presence of 33P-ATP (Rvb = 102.91%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antifungal activity against Candida albicans ATCC 90028 assessed as inhibition of metabolic activity at 10 ug\/ml after 48 hrs in presence of 80 ug\/ml fluconazol by XTT assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human EPHB1 (565 to 984 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant human full length N-terminal His6-tagged and N-terminal GST-tagged CDK5\/p35 expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length BMPR1A (Q214 to I532 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of FAM-labeled HIF-1alpha peptide from VBC (unknown origin) by fluorescence polarization assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length ULK2 (M1 to S301 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to partial length human PAK2 (P151 to R525 residues) expressed in bacterial expression system by KINOMEscan assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human partial length KIT V559D\/V654A double mutant (Y545 to D952 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length PIKFYVE (F1512 to C2098 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of wild-type human full length MEK2 (M1 to V400 residues) expressed in mammalian expression system at 1 uM by Kinomescan method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of GGPPs in human RPMI8226 cells assessed as disruption of Rap1a geranylgeranylation at 1 to 10 uM after 48 hrs by immunoblot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Protac activity against VHL\/MEK1 in human SK-MEL-28 cells harboring with BRAF V600E variant assessed as degradation of MEK1 at 0.1 to 0.3 uM after 4 hrs by Western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of MexXY\/OPRM in Pseudomonas aeruginosa C61 assessed as reduction in bacterial resistance to tobramycin by measuring fold reduction in tobramycin MIC at 80 ug\/ml incubated for 24 to 48 hrs by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potency index, ratio of [Nle15]MG11 IC50 to test compound IC50 for displacement of [177Lu] PP-F11N from CCK2R (unknown origin) transfected in A431 cells incubated for 1 hr at 4 degree C followed by compound washout with PBS buffer using Lu3+ labeled compound by Cobra-2 gamma counter method","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]4-DAMP from recombinant human M3 receptor after 60 mins by scintillation counting analysis","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant human LSD1 (172 to 852 residues) using biotin-labelled H3K4me2 (1 to 24 residues) after 1 hr by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length DRAK2 (M1 to C372 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to truncated human N-terminal His6-tagged LDH-H expressed in Escherichia coli Rosetta (DE3) in sodium phosphate buffer at pH 7.6 by WaterLOGSY NMR analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human A549 cells assessed as cell survival up to 10 uM incubated for 24 hrs by CCK8 assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]diprenorphine from rat delta opioid receptor expressed in rat C6 cell membranes measured after 1 hr by liquid scintillation counting method","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiviral activity against wild-type HIV1 NL4-3 infected infected in human MT2 cells assessed as reduction in extracellular RNA at 1 uM and measured after 30 hrs post infection by Alu-LTR PCR protocol based method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antiinflammatory activity in Sprague-Dawley rat assessed as inhibition of croton oil-induced ear edema at 15 mg\/kg, ip administered 1 hr before croton oil challenge measured after 3 hrs post challenge relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human partial length BRDT bromodomain 1 (N21 to E137 residues) expressed in bacterial expression system by BROMOscan assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to BLM in human HCT116 cells cotransfected with DSB model and I-SceI plasmid assessed as reduction in recruitment of protein to DSB site in DNA at 1 uM measured after 24 hrs by chromatin immunoprecipitation assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Activation of human FXR LBD expressed in HEK293T cells assessed as induction of receptor activation at 30 uM incubated for 12 to 14 hrs by luciferase reporter gene assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA (unknown origin) at 0.25 to 0.5 mM by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA (unknown origin) at 0.1 to 0.2 mM by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to c-myc G-quadruplex DNA (unknown origin) in PBS buffer (40 mM K+, pH 7.4) by spectrofluorimetric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA after 24 hrs by UV-vis spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA isolated from human A549 cells assessed as intercalating activity at 100 uM after 1 hr by electrophoretic mobility shift assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in melting temperature at DNA to ligand ratio at 40:1 by spectrophotometric method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human HCC827 cells assessed as early apoptotic cells at 1 uM measured after 24 hrs by Annexin V-FITC\/propidium iodide staining based flow cytometry (Rvb = 2.49%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]DTG from sigma 2 receptor in rat PC12 cells incubated for 120 mins in presence of [3H]-(+)-pentazocine by liquid scintillation counting method","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to HPGDS (unknown origin) assessed as change in melting temperature by thermal shift assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to telomeric Htg24 G-quadruplex DNA G17A mutant (unknown origin) assessed as negative fluorescence signal at 5 uM under pH condition 7.4 by fluorescence titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Protac activity at human CDK13 in human Bel-7402 cells assessed as degradation of CDK13 at 0.1 to 30 uM measured after 24 hrs by Western blotting assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to FGFR4 (unknown origin) assessed as dissociation constant by competition binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Reactivation of NIMP-inhibited recombinant His-TEV-tagged human AChE expressed in CHO-K1 cells assessed as reactivation constant, Kr by measuring thiophenol levels by UV-vis absorption spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to D4 receptor (unknown origin) assessed as dissociation constant","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at STING in mouse RAW-Lucia ISG cells assessed as activation of ISG pathway incubated for 24 hrs by Quanti-Luc or Quanti-blue reagent based luminescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiproliferative against in mouse BaF3 EFGR Del19\/T790M\/C797S cell","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to His6-fused BRD3 BD2 (unknown origin) assessed as change in melting temperature at 100 uM incubated for 30 mins by thermal shift assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human Sirt3 (118 to 399 residues) assessed as dissociation constant (Koff) of ternary complex using acetylated MnSOD peptide as substrate in presence of OAADPr by short DNA nano levers based switchSENSE microfluid bio-chip analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human ERG at 10 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
